Brief: Canopy Growth And Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand
02/04/2025 12:31
April 2 (Reuters) - Canopy Growth Corp WEED.TO: CANOPY GROWTH AND SPECTRUM THERAPEUTICS ANNOUNCE SPECTRUM RESERVE, A NEW PREMIUM MEDICAL CANNABIS BRAND Source text: ID:nBw77TbXna Further company coverage: WEED.TO (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Canopy Growth
See all newsCanada's Canopy Growth Q4 revenue rises
Corrected: BRIEF-Canopy Growth Corp Q4 Revenue CAD 71.24 Million Vs. IBES Estimate CAD 74.4 Million
Brief: Canopy Growth Relaunches Tweed Brand In Germany With New Mtl Cannabis Strain Lineup, Marking First International Release Following Acquisition
Brief: Canopy Growth And Spectrum Therapeutics Expand Medical Portfolio With New 30 And 90-Pack Softgels And Enhanced Dosing Options
Focus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification